L-ELISA for human gas6 protein quantifies Hu Gas6 in cell culture media, plasma or human serum. The dosage will recognize only natural and recombinant human Gas6 protein.
L-ELISA for human gas6 protein quantifies Hu Gas6 in cell culture media, plasma or human serum. The dosage will recognize only natural and recombinant human Gas6 protein.
Method principle
L的ELISA (immuno-enzymatic test) solid phase sandwich of the human Gas6 protein is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-vested in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bound to immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), binding to the target on a different epitope from the capture antibody. A conjugate enzyme was incorporated into the assay. After incubation and washing steps to remove the microplate from the non-bonded substances, a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample.
Strict validation
Each batch manufactured from this ELISA kit is tested according to its quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
Gas6 (specific at growth cessation 6) showed 43% similarity with protein S. Its domain of gamma-carboxyglutamic acid (Gla) appears to be involved in stimulating cell proliferation. Gas6 is a ligand for tyrosine protein kinase receptors AXL, TYRO3 and MER. The GAS6/AXL signaling pathway plays a role in various processes such as endothelial cell survival during acidification by preventing apoptosis, optimal signaling of cytokines during the development of human natural killer cells, hepatic regeneration, survival and migration of gonadotrophin liberating hormone neurons, platelet activation or thrombotic response regulation.
Sensitivity
Sensitivity of the dosage: 0.65 pg/ml.
Measurement range
Dose range: 11.7-750 pg/ml.
Duration of dosing
Total duration of dosing: 3 h 30 min.
Reproducibility
Coefficient of intra-dose variation 2.6%, inter-dose 2.1%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15904214 |
| Specifications |
| Accession number | Q14393 |
| Dose range | 11.7-750 pg/ml |
| Sensitivity of the dosage | 0.65 pg/ml |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Type of sample | Cellular lysates, Serum, Surnatant, Supernatant |
| Target species | Human |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 2621 |
| Gene symbol(s) | GAS6 |
| Coefficient of inter-dose variation | 2.1% |
| Coefficient of intra-dose variation | 2.6% |
| Contents of kits | 96-well pre-coated plate, Standard (2 vials), Standard dilution stamp, Biotinylated detection anticorps, Streptavidine HRP, HRP diluent, Wash pad, Chromagen, Stop solution, Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 96 Tests |
| Regulatory status | RUO |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Serum, 5 μl; plasma, 5 μl; cell lysate, 5 μl; supernatant, 5 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 3 h 30 min |
Origin and customs
| Manufacturer ref. | BMS2291 |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.